LAYLAA 21
Identification of Laylaa 21
| No description |
Google image searchProduct monograph
Active ingredients
levonorgestrel, 100 MCG
ethinyl estradiol, 20 MCG
DIN: 02424282
Dosage form(s): TABLET
Route(s) of administration: ORAL
Description: 21 DAYS
Schedule: Prescription
Company: LUPIN PHARMA CANADA LIMITED
Date: 10-NOV-2023
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03A — HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (ATC, ATC/DDD)
- G03AA — Progestogens and estrogens, fixed combinations (ATC, ATC/DDD)
- G03AA07 — LEVONORGESTREL AND ESTROGEN (ATC/DDD)
Reference brand drug: Alesse
Pharmaceutical standard: MFR
